Federal contract award
75N92021P00258
TO PROCURE CRISPR GENE-EDITING OF THE ACVR1 AND TGFBR1 GENES IN ENDOMETRIAL CANCER CELL LINES FOR NHGRI.
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | NATIONAL INSTITUTES OF HEALTH NHLBI |
| NAICS | 541714 — Research and Development in Biotechnology (except Nanobiotechnology) |
| PSC | R499 — Other Professional Services |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $61.5K |
| Current contract value | $61.5K |
| Potential contract value / ceiling | $61.5K |
| Start date | Aug 2, 2021 |
| Current end date | Aug 2, 2024 |
| Potential end date | Aug 2, 2024 |
| Latest award activity | May 7, 2026 |
| Source loaded | Sep 19, 2026 |
Funding and modification history
Showing the latest 1 of 1 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| May 7, 2026 | P00003 | $-25.3K | EO 14042 - TO PROCURE CRISPR GENE-EDITING OF THE ACVR1 AND TGFBR1 GENES IN ENDOMETRIAL CANCER CELL LINES FOR NHGRI. |
Buyer contacts from matching notices
Matched on exact award/solicitation identifier and awarding agency. Source dates describe the notice, not current contact verification.
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| Maxwell, Dorothy L. | Contact | dorothy.maxwell@nih.gov 301-827-7729 | Source | Jul 22, 2021 |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.